Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Como a cirurgia bariátrica afeta as experiências sociais e o bem-estar - o estudo BaSES (BaSES)

17 de setembro de 2026 atualizado por: Jøran Hjelmesæth, The Hospital of Vestfold

Como o bypass gástrico e a gastrectomia vertical mudam experiências sociais e biomarcadores de bem-estar

Nonrandomized controlled trial to assess whether or not sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) affect social experiences and biomarkers of well-being 6 weeks and 1 year after surgery. The decision whether SG or RYGB will be performed is determined by medical decision making. Hypotheses: Bariatric surgery influences social experiences and well-being through changes in body image, reward responsivity and gut hormones. These changes may differ between gastric bypass (RYGB) and sleeve gastrectomy (SG).

Visão geral do estudo

Descrição detalhada

Explanation for choice of comparators

Obesity is one of the world's most serious public health problems. Conservative weight reduction methods alone (diet, exercise) often show disappointing results, as the majority of people who lose weight regain it after a shorter or longer period of time. The currently most effective measure to achieve a durable weight-loss is bariatric surgery.

When investigating the effectiveness of bariatric surgery, the focus has most often been on weight loss and obesity-related complications, while effects on social interaction and subjective experience have received much less attention. A large body of evidence has demonstrated that (supportive) social relationships benefit health. Individuals with low compared to those with high levels of social connectedness are more likely to die prematurely; and social relationships can also affect a range of other health conditions such as cardiovascular disease, cancer, and immune function. Importantly, individuals with obesity may experience social interactions as less positive than normal-weight individuals. They recount avoiding social events and relationships, but also career opportunities, shopping and other activities where they feel observed because of weight stigma. Such avoidance behavior can lead to a "chronic disengagement" with many aspects of social life, which in turn might decrease interpersonal skills. Further investigations into the link between social behavior and eating found that greater emotional eating is associated with greater social avoidance. Eating was described a means to cope with loneliness on the one hand, while on the other hand aggravating feelings of being alone due to the stigma associated with obesity. This way, loneliness and obesity can create a vicious circle. In terms of how bariatric surgery influences social interactions, one 10-year follow up study found improvements in social interactions for bariatric surgery, but not for conventional weight loss treatment. In qualitative studies, many participants mentioned that they received more positive social feedback following bariatric surgery, and that they enjoyed social activities more than before, although they also describe ambiguous feelings.

The present study will investigate whether and how two types of bariatric surgery improve the response to a range of social aspects of patients' daily lives. Further, it aims to determine potential mechanisms leading to these effects, namely changes in body image, gut hormones, and reward responsivity.

Tipo de estudo

Intervencional

Inscrição (Real)

134

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Vestfold
      • Tønsberg, Vestfold, Noruega, 3103
        • Morbid Obesity Center

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 80 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • scheduled for bariatric surgery and eligible for sleeve gastrectomy or gastric bypass
  • able to give consent
  • understand written and spoken Norwegian

Exclusion Criteria:

  • pregnancy and breast-feeding
  • chronic disease (endocrine, heart, neurological, lung, gastrointestinal, kidney)
  • cancer
  • acute psychotic episode

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Pesquisa de serviços de saúde
  • Alocação: Não randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Comparador Ativo: Gastric bypass

Gastric bypass

In Roux-en-Y gastric bypass (RYGB), the left crus will be dissected free, any hiatal hernia left in place. The minor curvature is opened at the second vessel and the lesser sac entered. A 25 mL gastric pouch will be created by firing one horizontal and two vertical staple loads. The ligament of Treitz is then identified and a proximal loop of small intestine anastomosed to the pouch 60 cm from the ligament of Treitz with one linear stapler (full length of the stapler), creating an antecolic, antegastric alimentary limb. The opening will be closed using a single row, running absorbable suture. An entero-enteroanastomosis will be made 120 cm distal of the gastro-enteroanastomosis. The introductory opening is closed with a single row, running absorbable suture. The small intestine will be divided with one load between the gastro-entero-enteroanastomosis and the entero-enteroanastomosis in order to complete a bypass with an alimentary limb of 120 cm and a biliopancreatic limb of 60 cm.

Comparador Ativo: Sleeve gastrectomy

Sleeve gastrectomy

In sleeve gastrectomy (SG) a large part (80%) of the ventricle is removed. The greater curvature will be dissected free starting 4-5 cm from the pylorus up to the angle of Hiss. The left crus is then visualized and inspected for hiatal hernia. Small sliding hernias and wide hiatus are left in situ. The ventricle will then be lifted and any adhesions in the lesser sac divided. A 35 Fr bougie is placed down to the pylorus guiding the creation of a tubular sleeve with linear staplers. The first two loads are always green or purple, while blue or tan loads are used for the rest of the ventricle. The last stapler is placed 5 mm laterally to the angle of Hiss. The staple line will then be inspected and secured with clips for additional haemostasis, no oversewing or buttressing material is routinely used.

Experimental: Single anastomosis sleeve ileal (SASI) bypass

Exploratory small arm with a small number of particpants

The SASI bypass will performed with a similar entry of the abdominal cavity. A 6-port set up and a liver retractor is utilized. The small bowel is measured 300cm from the ileocecal valve, in sequences of 10cm, with the small bowel stretched and markers placed on the graspers, and connected to the antrum of the stomach with a 45mm stapler. The anastomosis is positioned slightly ventral on the antrum. The antrum is opened ventrally 5 cm proximal to the pylorus, just below the horizontal axis of canalis pylori. A 12 mm port positioned left to the midline is used for introduction of the stapler, which is directed distally from the patient's left to right side. 2.5 cm of the 45 mm stapler device is used for firing the anastomosis, which is completed with a 2-0 PDS running suture. The fascia defect is closed for the port where the specimen is extracted. The mesenteric defect is not closed.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
1-year changes in Social Experience
Prazo: Change from 4 weeks before surgery to 1 year after surgery

10-item checklist assessing frequency and quality of daily social interactions (preprint in August 2025: https://osf.io/preprints/psyarxiv/6psar_v2); 2 sub-scales: (1) Being with others, (2) Being alone; the diary will be filled in 14 days in a row at the end of the day. Scale (1) was designed to measure enjoyment of being with others and the duration of social contact (6 items, range: 4 to 62.4), higher values indicate more enjoyment and a higher frequency of social contact. Scale (2) was designed to measure enjoyment of being alone (3 items, range: -5 to 20), higher values here indicate more enjoyment of being alone. An additional item at the beginning of the checklists asks how many people the respondent has had social contact with during the day (5 categories).

Change from 4 weeks before surgery to 1 year after surgery

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Changes in affect ratings after social evaluation (inclusion and exclusion)
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Positive and Negative Affect Schedule (PANAS): The PANAS is a self-report measure that is made up of two mood scales of 10 adjectives each, one measuring positive affect and the other one measuring negative affect. (1) Positive Affect Scale (range: 10-50; higher values indicate higher positive affect); (2) Negative Affect Scale (range: 10-50, higher values indicate higher negative affect)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in experience ratings after social evaluation (inclusion and exclusion)
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Need-Threat Scale: 4 sub-scales: (1) Belonging, (2) Self-Esteem, (3) Meaningful existence, (4) Control; range: 3-27 per sub-scale; higher values indicate more belonging, higher self-esteem, higher meaningful existence, and more control)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in pleasantness ratings in response to touch stimulation on the forearm
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Subjective ratings on a digitally presented visual analogue scale (VAS) scale: range 0-100 (unpleasant - pleasant) after a touch stimulation to the forearm (repeated 10 times)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in pleasantness ratings in response to self-stroking on the forearm
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Subjective ratings on a digitally presented VAS scale: range 0-100 (unpleasant - pleasant), after participants made 10 back-and-forth strokes on their forearm with their hand

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in intensity ratings in response to touch stimulation on the forearm
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Subjective ratings on a digitally presented VAS scale: range 0-100 (not intense - intense), after a touch stimulation to the forearm (repeated 10 times)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in intensity ratings in response to self-stroking on the forearm
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Subjective ratings on a digitally presented VAS scale: range 0-100 (not intense - intense), after participants made 10 back-and-forth strokes on their forearm with their hand

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in self-stroking velocity
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Participants are instructed to stroke their own forearm with a velocity they experience as pleasant. The duration of 10 back-and-forth strokes over a 10 cm distance on the forearm will be measured with a stop watch. Velocity in cm/sec will be calculated thereafter.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in cortisol levels from hair samples
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Cortisol (in pg/mg)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in endocannabinoid levels from hair samples
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Endocannabinoids (in pg/mg)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in fasting ghrelin levels from blood samples
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Ghrelin (in pg/ml)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in body image
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaires: Appearance Evaluation Scale (AES) and the Body Areas Satisfaction Scale (BASS) - the AES was designed to measure overall satisfaction/dissatisfaction with one's appearance and physical attractiveness. It has 7 items (range: 5-35) with high scores indicating body satisfaction and low scores indicating body dissatisfaction. The BASS was designed to measure the degree of dissatisfaction-satisfaction with specific body areas and attributes (range: 9-45). Higher scores indicate greater body satisfaction and lower scores indicate greater body dissatisfaction.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in reward responsivity
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaire: Temporal Experience of Pleasure Scale (TEPS) - the TEPS was designed to measure individual trait dispositions in both anticipatory and consummatory experiences of pleasure. It consists of 18 items, of which 10 form the (1) anticipatory pleasure scale (range: 10-60), and (2) 8 items for the consummatory pleasure scale (range: 8-48). Higher values on (1) indicate enhanced reward responsiveness and imagery, while higher values on (2) indicate higher openness to different experiences and appreciation of positive stimuli.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in interoceptive ability
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaire: Body Awareness Questionnaire (BAQ) - the BAQ was designed to assess self-reported attentiveness to normal nonemotive body processes, such as sensitivity to body rhythms, ability to detect small changes in normal bodily functioning, and one's ability to anticipate bodily reactions. It consists of 18 items (range: 18-126). Higher values indicate a higher sensitivity and awareness of one's bodily states.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in belongingness
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaires: The Social Connectedness Scale Revised (SCS-R) and the Social Assurance Scale (SAS). The SCS-R was designed to measure a psychological sense of belonging, or how individuals cognitively construe interpersonal closeness with others in their social world. It consists of 20 items (range: 20-120), with higher values indicating a higher sense of belonging. The SAS was designed to measure the importance of assurance from one's social group.It consists of 8 items (range: 8-48), with higher values indicating a higher need for social assurance.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in social network size
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaire: The Social Network Index (SNI) - the SNI was designed to measure three aspects of one's social networks: (1) network diversity, (2) number of people in the network, and (3) number of embedded networks. Each of the three sub-scales is assessed on 12 items. (1) refers to the number of high-contact roles (range: 0-12), with higher values indicating a higher number of social roles. (2) refers to the total number of people with whom the respondent has regular contact, which will be summed for the 12 items (range: 0-70). Higher numbers indicate more people in one's network (to not inflate the number, items 4-12 will be scored with 7 in case the reported number of people in this group is equivalent or larger to 7). The embedded network scale (3) reflects the number of different network domains in which a respondent is active (range: 0-8), with higher numbers indicating activity in more network domains.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in self-reported eating patterns
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaire:The Three Factor Eating Questionnaire -R 21 (TFEQ-R21) measures eating behaviour and has been validated for use in individuals with obesity and will be used in the study. It consists of 21 items comprising three domain scores; (1) uncontrolled eating; assessing the tendency to lose control over eating when feeling hungry or when exposed to external stimuli, (2) cognitive restraint; assessing the conscious restriction of food intake to control body weight or body shape, and (3) emotional eating; assessing overeating related to negative mood states. The domain scores were transformed to 0-100 scales to facilitate comparison; a higher score indicates more uncontrolled, restraint, or emotional eating.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in symptoms of depression and anxiety
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaire: Hospital Anxiety and Depression Scale (HADS). The validated generic HADS measures symptoms of anxiety and depression using 14 items scored from 0-3 It is decomposed into two domains measuring depression (HADS-D) and anxiety (HADS-A), both consisting of seven items yielding a score from 0-21.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in Health Related Quality of Life 1
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Generic questionnaire: Short Form-36 Health Survey (SF-36). Each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores for each of the 8 domains and summary scores for physical and mental health will be calculated.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in Health Related Quality of Life 2
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaire: Weight-related Symptom Measure (WRSM). The validated obesity specific WRSM measures 20 symptoms commonly related to being overweight or obese, including foot problems, joint pain, sensitivity to cold, shortness of breath, etc. using two different sets of items. The first set assesses whether or not a patient is experiencing specific symptoms, and the second set rates the level of the distress of the symptoms with values from zero ("not at all") to six ("bothers a very great deal"). The first set creates an additive scale summing symptoms from 0-20, while the second forms a symptom distress scale ranging from 0-120.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in Health Related Quality of Life 3
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Obesity specific questionnaire: The Impact of Weight on Quality of Life-Lite (IWQOL-lite). The IWQOL-Lite is a 31-item measure of weight-related quality of life. There are five domain scores (Physical Function, Self-Esteem, Sexual Life, Public Distress and Work) and a total score. Scores for all domains and total score range from 0-100, with lower scores indicating greater impairment.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
6-week Changes in Social Experience
Prazo: Change from 4 weeks before surgery to 6 weeks after surgery

10-item checklist assessing frequency and quality of daily social interactions (preprint in August 2025: https://osf.io/preprints/psyarxiv/6psar_v2); 2 sub-scales: (1) Being with others, (2) Being alone; the diary will be filled in 14 days in a row at the end of the day. Scale (1) was designed to measure enjoyment of being with others and the duration of social contact (6 items, range: 4 to 62.4), higher values indicate more enjoyment and a higher frequency of social contact. Scale (2) was designed to measure enjoyment of being alone (3 items, range: -5 to 20), higher values here indicate more enjoyment of being alone. An additional item at the beginning of the checklists asks how many people the respondent has had social contact with during the day (5 categories).

Change from 4 weeks before surgery to 6 weeks after surgery
Group differences between SG and RYBG patients in the above-mentioned outcomes [1-22]
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

The above-mentioned outcomes will be tested for differences between the two surgery types.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Change in Body Mass Index (BMI)
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

calculated from height (in cm) and weight (in kg) as kg/m^2

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in weight
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Percent total weight loss (%TWL) and in kg

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in anthropometric measures
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Waist and hip circumference (cm)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in body fat
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Body fat (in %)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in fat-free mass
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Fat-free mass (in kg)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in blood pressure
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Systolic and diastolic blood pressure (mm/Hg)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in lipids
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Total-cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides (all in mmol/l)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in glucose parameters
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

HbA1c (mmol/mol); C-peptide (nmol/l)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in C-reactive protein (CRP)
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

CRP (mg/L)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in blood enzymes
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

ASAT (aspartate aminotransferase), ALAT (alanine-aminotransferase), LD (lactate dehydrogenase), Gamma-GT (gamma-glutamyl transferase), ALP (alkaline phosphatase) (all in U/L)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in hemoglobin
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Hemoglobin (g/100 ml)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in ferritin
Prazo: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Ferritin ((µg/L)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Colaboradores

Investigadores

  • Investigador principal: Jøran Hjelmesæth, Professor, The Hospital of Vestfold

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

12 de maio de 2022

Conclusão Primária (Real)

5 de novembro de 2025

Conclusão do estudo (Real)

5 de novembro de 2025

Datas de inscrição no estudo

Enviado pela primeira vez

8 de dezembro de 2021

Enviado pela primeira vez que atendeu aos critérios de CQ

12 de janeiro de 2022

Primeira postagem (Real)

26 de janeiro de 2022

Atualizações de registro de estudo

Última Atualização Postada (Real)

22 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

17 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

De-anonymized individual participant data can be made available following publication upon reasonable request to authors Jøran Hjelmesæth and Uta Sailer. Data will be shared according to the consent given by the participants and Norwegian laws and legislation.

Prazo de Compartilhamento de IPD

For at least 10 years after publication

Critérios de acesso de compartilhamento IPD

All requests must be handled within the legal framework of Norway; non-commercial use of de-anonymized data

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever